China Oncology

Loading...

Welcome to China Oncology,

China Oncology

30 August 2018, Volume 28 Issue 8 Previous Issue Next Issue

GRM4 positive allosteric modulators inhibit breast cancer cell proliferation and promote cell apoptosis

LI Linhai, XIAO Bin, GUO Zixuan, et al

2018, 28 (8): 561-566. doi: 10.19401/j.cnki.1007-3639.2018.08.001

Abstract ( 429) PDF (2767KB) ( 1120 )

RIPK4 participates in osteosarcoma cell proliferation by regulating the Notch-Wnt signaling pathway

HAO Junlong, YANG Kai, WANG Yapeng, et al

2018, 28 (8): 567-576. doi: 10.19401/j.cnki.1007-3639.2018.08.002

Abstract ( 398) PDF (2661KB) ( 1217 )

Subsets and clinical significance of CD4⁺, CD8⁺and CD28⁺ T lymphocytes in the patients with colorectal carcinoma and adenoma

ZHANG Quan, QIU Sifang, ZHAO Kui, et al

2018, 28 (8): 577-583. doi: 10.19401/j.cnki.1007-3639.2018.08.003

Abstract ( 412) PDF (1795KB) ( 1766 )

Study on BRCA1/2 and ATM germline mutations in the Chinese prostate cancer patients

WU Junlong, GU Weijie, QIN Xiaojian, et al

2018, 28 (8): 584-589. doi: 10.19401/j.cnki.1007-3639.2018.08.004

Abstract ( 571) PDF (1336KB) ( 1631 )

The value of ¹⁸F-FDG PET/CT texture analysis in predicting neoadjuvant chemoradiotherapy of locally advanced rectal cancer

ZHENG Yingying,XU Junyan,ZHANG Jianping, et al

2018, 28 (8): 590-594. doi: 10.19401/j.cnki.1007-3639.2018.08.005

Abstract ( 427) PDF (1028KB) ( 1332 )

Prognostic analysis of sleeve lobectomy for non-small cell lung cancer

ZHENG Jiajie,GU Chang, LUO Jizhuang, et al

2018, 28 (8): 595-601. doi: 10.19401/j.cnki.1007-3639.2018.08.006

Abstract ( 446) PDF (1017KB) ( 1560 )

Clinical efficacy of GP, PF and TPF chemotherapy combined with intensity-modulated radiotherapy for nasopharyngeal carcinoma

YANG Youqi, OU Xiaomin, ZHOU Xin, et al

2018, 28 (8): 602-608. doi: 10.19401/j.cnki.1007-3639.2018.08.007

Abstract ( 975) PDF (1216KB) ( 2299 )

Progress in selective elimination of breast surgery after neoadjuvant chemotherapy for breast cancer

SHI Zhiqiang, QIU Pengfei, CONG Binbin, et al

2018, 28 (8): 609-613. doi: 10.19401/j.cnki.1007-3639.2018.08.008

Abstract ( 405) PDF (1046KB) ( 1250 )

Diagnosis and management of giant cell tumor of bone in the spine: a brief review

HUANG Wending, CAI Weiluo, LI Junkuan, et al

2018, 28 (8): 614-621. doi: 10.19401/j.cnki.1007-3639.2018.08.009

Abstract ( 433) PDF (1071KB) ( 1114 )

Clinical characteristics, diagnosis and treatment of intra-abdominal aggressive fibromatosis

CHEN Jinhu, YE Qing, HUANG Feng

2018, 28 (8): 622-626. doi: 10.19401/j.cnki.1007-3639.2018.08.010

Abstract ( 267) PDF (1043KB) ( 1095 )

Expert consensus on genetic testing in Chinese prostate cancer patients (2018 edition)

Prostate Cancer Working Group of China Anti-Cancer Association Genitourinary Cancer Committee

2018, 28 (8): 627-633. doi: 10.19401/j.cnki.1007-3639.2018.08.011

Abstract ( 623) PDF (984KB) ( 2282 )

中国癌症杂志

Database Indexing

A Guide to the Core Journals of China
Chinese Science Citation Database (CSCD)
China National Knowledge Infrastructure (CNKI)
Chinese Sci-tech Paper and Citation Database (CSTPCD)
Outsanding S&T Journals of China (2020) (F5000)
World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
SCOPUS
EMBASE
DOAJ
Chemical Abstracts (CA)
Japan Science and Technology Database (JST)
The Western Pacific Region Index Medicus (WPRIM)
EBSCO
Index of Copernicus International (ICI)

Competent Authorities

　The Ministry of Education of the People’s Republic of China

Sponsored by

　Fudan University Shanghai Cancer Center

Edited by

　Editorial Board of China Oncology

Editor-in-Chief

　SHAO Zhimin

Honorary Editor-in-Chief

　TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

　Shanghai Ouyang Printing Co., Ltd.

WeChat